哮喘合并COVID-19患者的尸检肺部发现
本文报告一名37岁哮喘男性在COVID-19发病不到2周内死亡,符合重度急性呼吸窘迫综合征临床标准;尸检肺组织显示黏液栓、哮喘相关组织学改变、早期弥漫性肺泡损伤及纤维素性肺炎,未见中性粒细胞丰富的急性支气管肺炎。
要点
- 哮喘合并COVID-19患者尸检可见黏液栓及早期弥漫性肺泡损伤。
- 弥漫性肺泡损伤模式与SARS-CoV和MERS-CoV尸检肺部描述相似。
- 缺乏中性粒细胞丰富的急性支气管肺炎有别于流感典型组织学改变。
核心结论
- 哮喘合并COVID-19死亡患者尸检肺组织显示哮喘相关改变及早期弥漫性肺泡损伤和纤维素性肺炎。
- 黏液栓对低氧血症的相对贡献尚不明确。
研究设计与样本
- 病例报告:一名37岁哮喘男性COVID-19死亡患者的尸检肺部组织学发现。
主要发现
- 肺组织显示黏液栓及其他归因于哮喘的组织学改变。
- 肺组织显示早期弥漫性肺泡损伤和纤维素性肺炎。
- 缺乏中性粒细胞丰富的急性支气管肺炎。
关键数值与推荐
- 患者符合重度急性呼吸窘迫综合征的临床标准。
- 患者在就诊后不到2周内死亡。
临床怎么用
- 哮喘合并COVID-19重症患者尸检肺损伤模式与SARS-CoV和MERS-CoV相似。
- 组织学缺乏中性粒细胞丰富急性支气管肺炎有别于流感典型改变。
局限性
- 为单个病例报告,结果外推需谨慎。
- 黏液栓对低氧血症的相对贡献未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Asthma is increasingly recognized as an underlying risk factor for severe respiratory disease in patients with coronavirus disease 2019 (COVID-19), particularly in the United States. Here, we report the postmortem lung findings from a 37-year-old man with asthma, who met the clinical criteria for severe acute respiratory distress syndrome and died of COVID-19 less than 2 weeks after presentation to the hospital. His lungs showed mucus plugging and other histologic changes attributable to asthma, as well as early diffuse alveolar damage and a fibrinous pneumonia. The presence of diffuse alveolar damage is similar to descriptions of autopsy lung findings from patients with severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus, and the absence of a neutrophil-rich acute bronchopneumonia differs from the histologic changes typical of influenza. The relative contribution of mucus plugging to his hypoxemia is unknown.
引用
- Konopka KE, Wilson A, Myers JL, et al. Postmortem Lung Findings in a Patient With Asthma and Coronavirus Disease 2019. Chest. 2020. PMID: 32360729. doi:10.1016/j.chest.2020.04.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。